Advanced a/LCI systems for improved clinical utility
先进的 a/LCI 系统可提高临床实用性
基本信息
- 批准号:10049233
- 负责人:
- 金额:$ 55.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-13 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdoptionAdvocateAffectAftercareAreaBarrett EsophagusBiologicalBiological MarkersBiophotonicsBiopsyCathetersCell NucleusCell SizeCervicalChronicClinicalClinical ResearchClinical TrialsColumnar EpitheliumComputer softwareConduct Clinical TrialsConfocal MicroscopyDataDeglutitionDetectionDeveloped CountriesDiagnosisDiagnosticDiagnostic ProcedureDiseaseDysplasiaDysplasia in Barrett&aposs EsophagusEndoscopesEndoscopyEpithelialEsophageal AdenocarcinomaEsophageal DiseasesEsophageal TissueEsophagusFeedbackFiberFutureGastroesophageal reflux diseaseGoalsHealthHealth StatusImageIncidenceInterferometryIntestinesLightMalignant NeoplasmsMalignant neoplasm of esophagusManualsMeasurementMeasuresMetaplasiaMethodsModalityMorbidity - disease rateMorphologyMulti-modal optical imagingNorth CarolinaNuclearOperative Surgical ProceduresOptical Coherence TomographyOpticsOutcome StudyPatientsPatternPerformancePeriodicityPhasePhysiciansPredictive ValueProceduresProtocols documentationPublic HealthRadiofrequency Interstitial AblationResearchResearch Project GrantsResidual stateResolutionRiskRisk FactorsSamplingSampling ErrorsScanningSensitivity and SpecificitySpottingsSquamous EpitheliumStratum BasaleStructureSurfaceSystemTechniquesTechnologyTestingTherapeuticThermal Ablation TherapyTimeTissuesUniversitiesUpdateValidationVisualautomated analysisautomated segmentationbasecancer riskclinical practicedesigndetection platformesophageal glandimage guidedimaging approachimaging platformimaging systemimprovedin vivoinstrumentlight scatteringmortalitymultimodalityneoplasticnoveloptical fiberpremalignantresponsescreeningtoolusability
项目摘要
There is a critical unmet need for in vivo detection of dysplasia in patients with Barrett's esophagus
(BE), a neoplastic tissue state resulting from chronic acid reflux. BE is associated with an increased risk of
esophageal cancer, a disease with a high morbidity rate. Patients with BE undergo periodic endoscopic
surveillance with systematic biopsy to search for pre-cancerous, dysplastic tissues, at which point therapeutic
treatment by thermal ablation or surgery is indicated. These procedures are guided by white-light endoscopy
but since there is no visual evidence of at the tissue surface, efficacy for detecting dysplasia is limited.
Consequently, dysplasia goes undetected even though BE patients undergo regular endoscopic surveillance.
Optical diagnostic techniques have shown the ability to assess tissue health in vivo but none has been widely
adopted. Physicians have not taken up these techniques because they typically do not cover enough tissue
area to be effective or lack sufficient sensitivity and specificity for real-time dysplasia detection. For example,
angle-resolved low coherence interferometry (a/LCI) uses nuclear morphology measurements as a biomarker of
dysplastic change, with proven sensitivity and specificity for in vivo detection of dysplastic BE tissues. However,
a/LCI is a point probe modality, only examining tissues in one spot at a time. Here we seek to incorporate a/LCI
into a multimodal optical imaging platform that enables practical detection of dysplasia in BE.
The goal of this research project is to design, implement and test advanced multimodal optical imaging systems
to enable diagnosis of dysplasia in BE tissues. The following specific aims are proposed. 1) Update a/LCI
system with image guidance. The a/LCI system will be redesigned, capitalizing on advances in key spectrometer
components to improve utility. The optical fiber probe will be updated to incorporate image guidance using
optical coherence tomography (OCT), which will improve usability. 2) Implement real time feedback. Software
will be updated to include real time guidance of tissue orientation and health status. 3) Test new designs in
clinical study. Clinical study will confirm accuracy of a/LCI for detecting dysplasia while demonstrating
improvements in efficiency of new hardware and software. A sub-aim of this study will be to evaluate OCT for
guiding a/LCI measurements while also detecting residual sub-squamous BE glands which may persist after
therapy that remain a cancer risk. 4) Develop multipoint a/LCI probe. Demonstrate principle of wide area scans
using a/LCI, enabling multiple measurements without repositioning. Further advances will integrate this probe
into the form factor of a therapeutic probe, specifically the Barrx Halo 90, a 2 cm2 “paddle” that is mounted on
the outside of a standard endoscope. 5) Conduct clinical trial of multipoint probe. This final clinical study will test
the new form factor by comparing with the first trial in this project. Endpoints will be to determine the yield of
dysplastic positive biopsies while also assessing the amount of time needed to cover the tissue. Completion of
these aims will yield a clinically incisive diagnostic tool suitable for widespread adoption.
在Barrett食管患者体内检测异型增生的需求尚未得到满足
(BE)一种由慢性胃酸反流引起的肿瘤组织状态。BE与以下风险增加相关:
食管癌是一种发病率很高的疾病。BE患者定期接受内镜检查
通过系统性活检进行监测,以寻找癌前病变、发育异常组织,
需要通过热消融或外科手术进行治疗。这些程序是由白光内窥镜引导的
但是由于在组织表面没有可见的证据,检测发育异常的功效是有限的。
因此,即使BE患者接受定期内镜监测,发育不良也未被发现。
光学诊断技术已经显示出评估体内组织健康的能力,但还没有一种被广泛应用。
领养的医生们还没有采用这些技术,因为它们通常不能覆盖足够的组织
区域是有效的或缺乏足够的灵敏度和特异性的实时异型增生检测。比如说,
角分辨低相干干涉术(a/LCI)使用核形态学测量作为
发育异常变化,对于发育异常BE组织的体内检测具有已证实的灵敏度和特异性。然而,在这方面,
a/LCI是一种点探针模式,一次仅检查一个点的组织。在这里,我们寻求纳入/LCI
多模式光学成像平台,能够实际检测BE中的发育异常。
本研究项目的目标是设计、实现和测试先进的多模态光学成像系统
从而能够诊断BE组织中的发育异常。提出了以下具体目标。1)更新a/LCI
图像引导系统。a/LCI系统将重新设计,利用关键光谱仪的进步
组件以提高实用性。将更新光纤探头,以纳入图像引导,
光学相干断层扫描(OCT),这将提高可用性。2)实施真实的时间反馈。软件
将进行更新,以包括组织定向和健康状态的真实的实时指导。3)测试新设计
临床研究临床研究将证实a/LCI检测异型增生的准确性,同时证明
提高新硬件和软件的效率。本研究的子目标是评价OCT
指导a/LCI测量,同时还检测残留的鳞状下BE腺体,
治疗仍然有癌症风险。4)开发多点a/LCI探头。演示广域扫描原理
使用/LCI,无需重新定位即可进行多次测量。进一步的发展将把这个探测器
进入治疗探头的形状因子,特别是Barrx Halo 90,一个2 cm 2的“桨”,安装在
标准内窥镜的外部。5)进行多点探头的临床试验。这项最终的临床研究将测试
通过与该项目中的第一次试验进行比较,确定了新的形状因子。终点将是确定
发育异常阳性活检,同时还评估覆盖组织所需的时间量。完成
这些目标将产生适合广泛采用的临床上敏锐的诊断工具。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Esophageal OCT Imaging Using a Paddle Probe Externally Attached to Endoscope.
使用外部连接至内窥镜的桨式探头进行食管 OCT 成像。
- DOI:10.1007/s10620-021-07372-w
- 发表时间:2022
- 期刊:
- 影响因子:3.1
- 作者:Chu,KengyehK;Zhao,Yang;Jelly,EvanT;Steelman,ZacharyA;Crose,Michael;Cox,Brian;Ofori-Marfoh,Yaa;Moussa,Lama;Cirri,Holly;Watts,Ariel;Shaheen,Nicholas;Wax,Adam
- 通讯作者:Wax,Adam
Reconstruction of angle-resolved backscattering through a multimode fiber for cell nuclei and particle size determination.
通过多模光纤重建角度分辨反向散射,用于细胞核和颗粒尺寸测定。
- DOI:10.1063/5.0011500
- 发表时间:2020
- 期刊:
- 影响因子:5.6
- 作者:Zhang,Haoran;Steelman,ZacharyA;Ceballos,Silvia;Chu,KengyehK;Wax,Adam
- 通讯作者:Wax,Adam
Spatial scanning of a sample with two-dimensional angle-resolved low-coherence interferometry for analysis of anisotropic scatterers.
使用二维角度分辨低相干干涉仪对样品进行空间扫描,以分析各向异性散射体。
- DOI:10.1364/boe.398052
- 发表时间:2020
- 期刊:
- 影响因子:3.4
- 作者:Song,Ge;Steelman,ZacharyA;Kendall,Wesley;Park,HanSang;Wax,Adam
- 通讯作者:Wax,Adam
Optical coherence tomography of small intestine allograft biopsies using a handheld surgical probe.
- DOI:10.1117/1.jbo.26.9.096008
- 发表时间:2021-09
- 期刊:
- 影响因子:3.5
- 作者:Jelly ET;Kwun J;Schmitz R;Farris AB;Steelman ZA;Sudan DL;Knechtle SJ;Wax A
- 通讯作者:Wax A
Response to Comment on "Is the nuclear refractive index lower than cytoplasm? Validation of phase measurements and implications for light scattering technologies": A Comment on "How a phase image of a cell with nucleus refractive index smaller than that o
对“核折射率是否低于细胞质?相位测量的验证及其对光散射技术的影响”的评论的回应:对“核折射率小于细胞质的细胞的相位图像如何”的评论
- DOI:10.1002/jbio.201800091
- 发表时间:2018
- 期刊:
- 影响因子:2.8
- 作者:Steelman,ZacharyA;Eldridge,WillJ;Wax,Adam
- 通讯作者:Wax,Adam
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NICHOLAS J SHAHEEN其他文献
NICHOLAS J SHAHEEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NICHOLAS J SHAHEEN', 18)}}的其他基金
Advanced a/LCI systems for improved clinical utility
先进的 a/LCI 系统可提高临床实用性
- 批准号:
9261900 - 财政年份:2016
- 资助金额:
$ 55.3万 - 项目类别:
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
消融治疗后巴雷特食管的非内镜监测
- 批准号:
9341252 - 财政年份:2013
- 资助金额:
$ 55.3万 - 项目类别:
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
消融治疗后巴雷特食管的非内镜监测
- 批准号:
9139436 - 财政年份:2013
- 资助金额:
$ 55.3万 - 项目类别:
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
消融治疗后巴雷特食管的非内镜监测
- 批准号:
8735947 - 财政年份:2013
- 资助金额:
$ 55.3万 - 项目类别:
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
消融治疗后巴雷特食管的非内镜监测
- 批准号:
8618302 - 财政年份:2013
- 资助金额:
$ 55.3万 - 项目类别:
Perception of Cancer Risk in Patients with Barrett's
巴雷特氏症患者对癌症风险的认知
- 批准号:
7137036 - 财政年份:2006
- 资助金额:
$ 55.3万 - 项目类别:
The Perception of Cancer Risk in Patients with Barrett's Esophagus
巴雷特食管患者对癌症风险的认知
- 批准号:
7260521 - 财政年份:2006
- 资助金额:
$ 55.3万 - 项目类别:
Epidemiologic Case-control Study of Barrett's Esophagus
巴雷特食管流行病学病例对照研究
- 批准号:
6517872 - 财政年份:2001
- 资助金额:
$ 55.3万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 55.3万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 55.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 55.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 55.3万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 55.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 55.3万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 55.3万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 55.3万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 55.3万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 55.3万 - 项目类别:
Standard Grant














{{item.name}}会员




